SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-043278
Filing Date
2023-07-25
Accepted
2023-07-25 12:33:06
Documents
1
Period of Report
2023-07-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3995
  Complete submission text file 0001209191-23-043278.txt   5411
Mailing Address 40 GUEST STREET BOSTON MA 02135
Business Address 40 GUEST STREET BOSTON MA 02135 617-949-2680
Cue Biopharma, Inc. (Issuer) CIK: 0001645460 (see all company filings)

IRS No.: 473324577 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CUE BIOPHARMA, INC. 40 GUEST STREET BOSTON MA 02135
Business Address
Levisetti Matteo (Reporting) CIK: 0001962444 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38327 | Film No.: 231107650